These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 689849)

  • 1. Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst.
    Dourish CT; Cooper SJ
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():19-23. PubMed ID: 689849
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
    Carruba MO; Ricciardi S; Mantegazza P
    Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
    [No Abstract]   [Full Text] [Related]  

  • 3. Sedation, stereotypy and the inhibition of drinking after administration of ET 495 in the rat [proceedings].
    Cooper SJ; Dourish CT
    Br J Pharmacol; 1979 Jul; 66(3):481P. PubMed ID: 575064
    [No Abstract]   [Full Text] [Related]  

  • 4. [The search for compounds with dopaminergic activity. VII. Synthesis of piribedil analogs].
    Woliński J; Kujawa T; Prokopienko G; Rafalska B
    Acta Pol Pharm; 1988; 45(3):206-9. PubMed ID: 3239429
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat.
    Dourish CT; Cooper SJ
    Psychopharmacology (Berl); 1981; 72(2):197-202. PubMed ID: 6782611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of responsiveness to dopaminergic agonists.
    Reinstein DK; McClearn D; Isaacson RL
    Brain Res; 1978 Jul; 150(1):216-23. PubMed ID: 566610
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurochemical effects of ET 495 : mechanism of action.
    Hiremagalur J; Keshavan H; Gurbani NK; Dandiya PC
    Pharmacol Res Commun; 1981 Jun; 13(6):607-15. PubMed ID: 6170078
    [No Abstract]   [Full Text] [Related]  

  • 8. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):3-27. PubMed ID: 6304814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral dopaminergic mechanisms. Present status of the problem].
    Oules MJ; Boscredon J
    Ann Med Psychol (Paris); 1979 Nov; 137(9):925-9. PubMed ID: 232829
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral interactions between naloxone and dopamine agonists.
    Harris RA; Snell D; Loh HH; Way EL
    Eur J Pharmacol; 1977 Jun; 43(3):243-6. PubMed ID: 872878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of piribedil on body temperature in mice and rats.
    Kapturkiewicz Z; Sowińska H
    Pol J Pharmacol Pharm; 1977; 29(6):609-18. PubMed ID: 600860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)].
    Ohmoto T; Miyamoto T; Baba Y
    No To Shinkei; 1977 Jul; 29(7):?31-40. PubMed ID: 409419
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human].
    Ziegler M; Georgiadis G; Elghozi JL
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1186-90. PubMed ID: 6441537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of piribedil and of d-amphetamine on locomotor activity in immature rats.
    Dourish CT; Cooper SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):249-55. PubMed ID: 6539932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The search for compounds with dopaminergic action. V. Synthesis of piribedil analogs].
    Woliński J; Kujawa T
    Acta Pol Pharm; 1987; 44(2):143-6. PubMed ID: 2893511
    [No Abstract]   [Full Text] [Related]  

  • 17. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of a dopaminergic drug (piribedil) on pituitary hormone release in normal men and women.
    De Marinis L; Mancini A; Calabrò F; Massari M; Torlontano M; Barbarino A
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):385-9. PubMed ID: 6419519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight change during various neuropharmacologic manipulations in psychotic inpatients.
    Carman JS; Wyatt RJ; Nasrallah HA; O'Brien P; Gillin JC
    Acta Cient Venez; 1978; 29(3):178-80. PubMed ID: 757726
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
    Porreca F; Cowan A; Tallarida RJ
    Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.